Year End Stock Prices. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends 24 Feb 2020 Shares of drug developer Gilead soared amid a broad market slump on a consensus price target of $74.91, according to Bloomberg data. 21 Feb 2020 Real-time trade and investing ideas on Gilead Sciences Inc. GILD from the largest community of traders and investors. Real time Gilead Sciences (GILD) stock price quote, stock graph, news Interactive Chart. 1W 1M The Fool has written over 1500 articles on Gilead Sciences. Real-time share price updates and latest news for Gilead Sciences Inc (NASDAQ :GILD). Compare across sectors Share Price Chart. 1d 1m 3m 6m 1y 3y 5y.
Discover historical prices for GILD stock on Yahoo Finance. View daily, weekly or monthly format back to when Gilead Sciences, Inc. stock was issued.
The Gilead Sciences 52-week high stock price is 80.40, which is 17.2% above the current share price. The Gilead Sciences 52-week low stock price is 60.89 , which is 11.2% below the current share price. View the latest Gilead Sciences Inc. (GILD) stock price, news, historical charts, analyst ratings and financial information from WSJ. Dow Jones, a News Corp company GILD | Complete Gilead Sciences Inc. stock news by MarketWatch. For two decades he reshaped General Electric with one eye always on the share price. GE easily outraced the S&P 500, but critics Gilead Sciences, Inc. Common Stock (GILD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
GILD's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low
Discover historical prices for GILD stock on Yahoo Finance. View daily, weekly or monthly format back to when Gilead Sciences, Inc. stock was issued. GILD Gilead Sciences, Inc. Common Stock (GILD) Historical Data. Showing items 1 to 18 of 21 records. Get up to 10 years of daily historical stock prices & volumes. Data provided by Edgar Online. All Gilead Sciences Inc. historial stock quotes by MarketWatch. View historical GILD stock price data to see stock performance over time. Gilead Sciences IncDrugs giant Gilead (GILD– Get Report) received the thumbs down from Goldman Sachs earlier this year. “We are downgrading GILD to Sell from Neutral and lowering our price target to $60 from $70 which represents -10% downside vs 17% avg upside for the rest of our coverage,” Terence Flynn wrote. The Gilead Sciences 52-week high stock price is 80.40, which is 17.2% above the current share price. The Gilead Sciences 52-week low stock price is 60.89 , which is 11.2% below the current share price. View the latest Gilead Sciences Inc. (GILD) stock price, news, historical charts, analyst ratings and financial information from WSJ. Dow Jones, a News Corp company
GILD shares outstanding history table and chart, presented by another trading at a price of $20 per share and think the latter company is worth twice as much.
Find the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing. Records 1 - 18 of 21 Get up to 10 years of daily historical stock prices & volumes. Data provided by Edgar Online. ©2019, EDGAR®Online, a division of Donnelley
All Gilead Sciences Inc. historial stock quotes by MarketWatch. View historical GILD stock price data to see stock performance over time.
GILD Stock Price Recovery History. This table allows you to know how fast GILD’s price was able to recover after paying out dividends in the past. As an Investor you can benefit from stocks that recover quickly by capturing the dividend payment without suffering stock price depreciation. Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases This was a 2 for 1 split, meaning for each share of GILD owned pre-split, the shareholder now owned 2 shares. For example, a 16000 share position pre-split, became a 32000 share position following the split. When a company such as Gilead Sciences splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Gilead (GILD) leads the race of companies developing treatments for coronavirus with experimental candidate, remdesivir, showing promise. The outbreak of COVID-19 has brought the volatile biotech sector under the spotlight as both large and small companies rush to develop treatments and vaccines to